Results 91 to 100 of about 1,188 (167)

Availability of New Medicines in the US and Germany From 2004 to 2018.

open access: yesJAMA Netw Open, 2022
Blankart K, Naci H, Chandra A.
europepmc   +1 more source

[Dupilumab has an additional benefit in treatment of chronic rhinosinusitis with nasal polyps]. [PDF]

open access: yesHNO, 2021
Klimek L   +6 more
europepmc   +1 more source

Advancing early access policies for innovative cancer drugs: a scoping review and explorative analysis in the Italian setting. [PDF]

open access: yesJ Pharm Policy Pract
d'Errico M   +5 more
europepmc   +1 more source

Shaping a suitable EU HTA dossier template: why the German template is not fit for purpose. [PDF]

open access: yesEur J Health Econ
Schweitzer MK   +11 more
europepmc   +1 more source

Topics in health economics and social policy : Abstracts of the 7th DIBOGS-Workshop, Düsseldorf 2012 [PDF]

open access: yes, 2013
Banduhn, Carolin   +8 more
core  

Indication-wide drug pricing: Insights from the pharma market. [PDF]

open access: yesJ Pharm Policy Pract, 2022
Siegmeier F, Büssgen M.
europepmc   +1 more source

Home - About - Disclaimer - Privacy